V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210001837 | 210001837 | null | null | null | 2016-11-03 | 2017-01-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100141422 |
| 210001843 | 210001843 | 1.72 | 74.9 | null | 2016-08-23 | 2016-08-23 | FEC + DOCETAXEL | 02 | N | PALBOCICLIB | 100424396 |
| 210001864 | 210001864 | null | null | null | 2018-10-08 | 2018-10-08 | EC | 02 | N | EC | 101063448 |
| 210001879 | 210001879 | null | null | null | 2016-04-16 | 2016-05-12 | FEC | 02 | N | CARBOPLATIN + DOCETAXEL | 100650094 |
| 210001900 | 210001900 | 1.67 | 58.25 | null | 2017-11-24 | 2017-12-09 | Carboplatin + Docetaxel | 02 | N | FEC + DOCETAXEL | 101096435 |
| 210001905 | 210001905 | null | null | null | 2019-02-19 | 2019-03-04 | Epirubicin (weekly) | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101092237 |
| 210001907 | 210001907 | null | null | Adjuvant (A) | 2017-09-14 | 2017-10-06 | null | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101084326 |
| 210001932 | 210001932 | null | null | null | null | 2019-12-04 | Everolimus 10mg | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101071136 |
| 210001940 | 210001940 | null | null | null | 2018-09-05 | 2018-09-17 | FEC 100 | N | N | FEC + DOCETAXEL | 100648385 |
| 210001944 | 210001944 | 1.68 | 85 | null | 2016-06-29 | 2016-07-01 | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 02 | N | DOCETAXEL | 101002234 |
| 210001960 | 210001960 | 1.48 | 87 | null | null | 2017-03-06 | FEC + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100683049 |
| 210001970 | 210001970 | 1.66 | 81 | null | 2018-06-19 | 2018-06-21 | PACLITAXEL | 02 | N | EVEROLIMUS | 100555834 |
| 210001972 | 210001972 | null | null | null | 2018-04-24 | 2018-04-26 | Capecitabine | 2 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101672086 |
| 210001976 | 210001976 | null | null | null | 2017-07-18 | 2017-08-09 | FEC + DOCETAXEL | null | null | FEC + TRASTUZUMAB | 100351657 |
| 210001990 | 210001990 | null | null | null | 2018-05-04 | 2018-05-11 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100182875 |
| 210001999 | 210001999 | null | null | null | null | 2019-09-16 | FEC 100 | N | null | FEC | 100201847 |
| 210002023 | 210002023 | null | null | null | 2019-06-24 | 2019-07-15 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | NERATINIB | 101431357 |
| 210002114 | 210002114 | 1.67 | 68.4 | null | null | 2016-05-08 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100753770 |
| 210002117 | 210002117 | null | null | null | null | 2017-10-13 | Irinotecan + Modified De Gramont | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101064074 |
| 210002122 | 210002122 | null | null | null | null | 2018-01-11 | EC | null | null | FEC | 101273372 |
| 210002127 | 210002127 | null | null | null | null | 2018-06-30 | FEC 100 | null | null | CARBOPLATIN + DOCETAXEL | 100657281 |
| 210002137 | 210002137 | 1.8 | 58.25 | null | null | 2016-03-28 | null | null | N | FEC | 100929503 |
| 210002141 | 210002141 | null | null | null | 2016-02-10 | 2016-02-11 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101826746 |
| 210002154 | 210002154 | 1.67 | 69.4 | null | null | 2016-05-30 | FEC 100 | null | N | FEC | 100827829 |
| 210002164 | 210002164 | 1.67 | 63 | null | 2018-05-31 | 2018-08-21 | FEC + DOCETAXEL | 02 | N | FEC | 101609360 |
| 210002190 | 210002190 | 1.72 | 62.25 | null | 2019-02-11 | 2019-02-25 | GEMCARBO | 02 | N | EC | 101413304 |
| 210002229 | 210002229 | 1.55 | 111.2 | null | 2018-11-12 | 2019-02-02 | FEC + DOCETAXEL | N | N | CARBOPLATIN | 101584469 |
| 210002232 | 210002232 | null | null | null | 2018-04-22 | 2018-04-30 | null | 02 | N | CAPECITABINE | 100284759 |
| 210002268 | 210002268 | 1.6 | 71.5 | null | null | 2018-06-11 | FEC + DOCETAXEL | null | N | PACLITAXEL | 101265629 |
| 210002280 | 210002280 | null | null | null | 2018-07-30 | 2018-08-23 | null | 02 | N | FEC + DOCETAXEL | 101392213 |
| 210002316 | 210002316 | 1.62 | 0 | null | 2017-02-28 | 2017-03-20 | FEC 100 | 02 | N | FEC | 100384883 |
| 210002348 | 210002348 | 1.75 | 96.5 | null | 2018-08-21 | 2018-09-08 | EC | N | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101239949 |
| 210002385 | 210002385 | null | null | Adjuvant (A) | 2018-03-24 | 2018-04-02 | EC | N | null | EC | 100278495 |
| 210002409 | 210002409 | null | null | Neo-adjuvant (N) | 2016-11-20 | 2016-11-23 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100336771 |
| 210002418 | 210002418 | null | null | Curative (C) | 2018-10-22 | 2018-11-29 | EC | null | N | CARBOPLATIN + PACLITAXEL | 101805602 |
| 210002436 | 210002436 | null | null | null | 2016-07-15 | 2016-07-21 | EC | 02 | N | FEC | 101297186 |
| 210002458 | 210002458 | 1.54 | 74 | null | null | 2016-10-10 | FEC 60 or 75 | null | N | FEC | 100000984 |
| 210002464 | 210002464 | null | null | null | null | 2018-07-22 | FEC + TRASTUZUMAB | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101255784 |
| 210002476 | 210002476 | 1.65 | 82.8 | null | 2018-05-06 | 2018-05-07 | Docetaxel 100mg/m2 (21 day) | 02 | Y | FEC | 100050182 |
| 210002486 | 210002486 | null | null | null | null | 2017-11-10 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100512600 |
| 210002487 | 210002487 | null | null | null | 2018-04-24 | 2018-04-24 | CARBOPLATIN + PACLITAXEL | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101683954 |
| 210002504 | 210002504 | null | null | null | 2016-07-13 | 2016-07-28 | null | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100581163 |
| 210002521 | 210002521 | 1.52 | 77.4 | null | 2018-08-14 | 2018-08-15 | Carboplatin 21day + Paclitaxel 7day | 02 | N | PACLITAXEL | 101405419 |
| 210002539 | 210002539 | null | null | Adjuvant (A) | null | 2018-07-26 | FEC 100 | N | N | CARBOPLATIN + PACLITAXEL | 100210041 |
| 210002541 | 210002541 | null | null | null | null | 2017-03-03 | PACLITAXEL | null | null | ROSCO TRIAL | 101723328 |
| 210002548 | 210002548 | null | null | Adjuvant (A) | 2017-02-22 | 2017-03-09 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100293159 |
| 210002552 | 210002552 | null | null | null | 2017-12-21 | 2018-03-14 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | DOCETAXEL | 101144102 |
| 210002553 | 210002553 | null | null | null | null | 2018-08-25 | FEC + DOCETAXEL | N | N | FEC | 100185005 |
| 210002554 | 210002554 | 1.61 | 89.5 | null | null | 2019-05-06 | EC | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101380221 |
| 210002567 | 210002567 | 1.57 | 87 | null | 2016-11-12 | 2016-11-20 | Docetaxel 75mg/m2 (21 day) | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101682300 |